Table 3 Concentration of lipid, apoAI, apoB and lipid and lipoprotein ratios in the control group, patients ≤ 50 years of age and > 50 years of age, and in subgroup patients with oldest age and the largest the CAP lesion size and in all patients, the median (min- max)

TG (mmol/L)

1.07(0.70–1.94)

1.27(0.65–3.37)

1.45(0.58–4.26)

1.34(0.58–4.26)

1.33(0.58–4.26)

TC (mmol/L)

4.92(4.35–5.69)

5.12(4.06–7.20)

5.51(3.80-7.40)

5.43(4.25–7.40)

5.38(3.80–7.40)

LDL-C (mmol/L)

3.15(2.20–3.62)

3.60(2.36–5.20)

4.06(2.14–5.23)

3.85(2.69–4.71)

3.78(2.14–5.23)

HDL-C (mmol/L)

1.42(1.13–2.40)

1.37(0.62–2.07)

1.13(0.49–1.99)

1.08(0.49–1.86)

1.16(0.49–2.07)

nHDL-C (mmol/L)

3.62(2.53–4.19)

3.85(2.66–5.82)

4.29(2.64–6.21)

4.06(3.15–6.11)

3.93(2.64–6.21)

apoAI (mg/L)

1680(1500–2030)

1500(790–2350)

1440(950–1820)

1420(1050–1820)

1440(790–2350)

apoB (mg/L)

880(620–1060)

760(520–1340)

970(500–1490)

800(500–1490)

870(500–1490)

TC/HDL-C

3.45(2.17–4.45)

3.67(2.56–6.00)

4.82(2.69–9.0)*

5.01(2.69–9.27)*

4.63(2.56–9.27)

LDL/HDL-C

2.22(1.11–3.72)

2.62(1.35–6.53)

3.57(1.97–9.53)*

3.52(1.54–6.31)*

3.24(1.35–9.53)

TG/HDL-C

1.78(1.0–3.2)

2.13(0.97–8.28)

2.83(0.72–11.8)*

2.83(0.72–7.54)*

2.56(0.72–11.8)

HDL-C/apoAI

0.33(0.32–0.47)

0.35(0.23–0.66)

0.30(0.16–0.50)

0.29(0.0.16–0.48)

0.31(0.16–0.66)

apoAI/apoB

1.89(1.17–3.27)

1.82(1.17–3.17)

1.49(0.70–2.55)*

1.77(0.80–2.45)

1.65(0.70–3.17)